Status:
UNKNOWN
Effect of Jing Si Herbal Tea on Inflammation in Patients With Cardiovascular Disease
Lead Sponsor:
Buddhist Tzu Chi General Hospital
Conditions:
Inflammatory Response
Gut Microbiome
Eligibility:
All Genders
20-75 years
Phase:
NA
Brief Summary
Jing Si herbal tea includes eight Chinese herbs: such as mugwort leaves, fish needle grass, Ophiopogon japonicus, platycodon, perilla leaves, chrysanthemum, and licorice. In vitro, these ingredients w...
Detailed Description
Jing Si herbal tea includes eight Chinese herbs: such as mugwort leaves, fish needle grass, Ophiopogon japonicus, platycodon, perilla leaves, chrysanthemum, and licorice. In vitro, these ingredients w...
Eligibility Criteria
Inclusion
- hypertension,
- hyperlipidemia,
- ischemic heart disease
- diabetes
Exclusion
- cancer patients,
- have comorbidities with poor control
- patients with eGFR\< 40 ml/min/1.73m2
- who are pregnant, breastfeeding, and in their menstrual period when recruiting
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05420987
Start Date
June 1 2022
End Date
December 1 2024
Last Update
June 16 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.